Drugs / adenoviral vector encoding rat Her-2/neu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00307229 | Mar 2006 → Jul 2009 | breast carcinoma | Ontario Clinical Oncology Group (OCOG) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adenoviral vector encoding rat Her-2/neu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307229 ↗ |
| Modality | Vaccine | “a vaccine consisting of adenovector expressing rat Her-2/neu” NCT00307229 ↗ |